全球伴侶動物疫苗市場按產品類型、類型、分銷管道和地區分類

Companion Animal Vaccine Market, By Product Type, By Species Type , By Distribution Channel, By Geography

出版日期: 2025年05月26日 | 出版商:

Coherent Market Insights | 英文 208 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

伴侶動物疫苗市場規模預計在 2025 年為 38.2 億美元，預計到 2032 年將達到 60.5 億美元，2025 年至 2032 年的複合年成長率為 6.8%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	38.2億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	6.80%	2032年價值預測	60.5億美元

伴侶動物疫苗在以經濟有效的方式改善伴侶動物健康方面發揮著至關重要的作用。這些疫苗對於減少可在動物之間或動物之間傳播的人際病毒性疾病也至關重要。美國FDA 獸醫中心 (CVM)核准用於伴侶動物（例如狗、貓和馬）以及食用動物（例如牛、豬和雞）的藥物。此外，預計在預測期內，對伴侶動物疾病（包括病毒性疾病）預防的監管力度不斷增加將推動全球伴侶動物市場的成長。例如，2016 年，美國動物醫院協會 (AAHA)委託一個由獸醫腫瘤學專家組成的工作小組制定了一套指南，幫助獸醫團隊與寵物飼主合作制定個人化治療計劃，從而改善癌症寵物的生活品質。

市場動態

新型伴侶動物疫苗的核准和上市數量不斷增加，市場主要企業採取收購和合作等無機成長策略，以及新型疫苗研發的不斷推進，預計將在預測期內推動全球伴侶動物疫苗市場的成長。例如，鑑於犬利甚曼病在全球多個地區（尤其是南歐和南美）的流行率不斷上升，法國動物護理公司維克（Virbac）於2019年3月推出了一款名為CANILEISH的疫苗，用於預防犬利什曼原蟲症利什曼原蟲症。

此外，2018 年 6 月，碩騰的 Fostera Gold PCV 獲得了美國農業部的上市核准，這是第一個用於養豬業的單價疫苗，含有兩種基因型的豬環狀病毒2 型 (PCV2)。

本研究的主要特點

本報告對全球伴侶動物疫苗市場進行了詳細分析，並提供了預測期 2025-2032 的市場規模和年複合成長率（CAGR%）（假設 2024 年為基準年）。
它還揭示了不同領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
全球伴侶動物疫苗市場的主要企業根據公司概況、績效、產品系列、市場影響、分銷策略、關鍵發展、策略和未來計劃等參數進行分析。
本報告的見解將使企業負責人和經營團隊能夠就未來的市場擴張和行銷策略做出明智的決策。
全球伴侶動物疫苗市場報告針對該行業的各個相關人員，包括投資者、產品開發商和製造商、經銷商、醫療機構、研發機構、新進業者和金融分析師。
透過用於分析全球伴侶動物疫苗市場的各種策略矩陣，相關人員可以在決策中獲得顯著利益。

公司簡介
- Elanco Animal Health Incorporated
- Boehringer Ingelheim GmbH
- Ceva Ltd.
- Merck &Co. Inc.
- Virbac
- Zoetis Inc.
- HIPRA
- Biogenesis Bago
- Ourofino Animal Health.
- Croda International Plc
- KM Biologics
- Indian Immunologicals Ltd.
- Sinovac
- Kyoto Biken Laboratories, Inc.
- HESTER BIOSCIENCES LIMITED
- Calier
- Bioveta, as

第9章章節

參考
調查方法

簡介目錄

Product Code: CMI3387

The Companion Animal Vaccine Market is estimated to be valued at USD 3.82 Bn in 2025 and is expected to reach USD 6.05 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 3.82 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.80%	2032 Value Projection:	USD 6.05 Bn

Companion animal vaccines play an important role in improving the health of companion animals in a cost effective manner. These vaccines are also important for reducing viral diseases transmitted from animals to animals or animals to humans. The U.S. FDA Center for Veterinary Medicine (CVM) approves drugs for companion (pet) animals such as dogs, cats, and horses and for food-producing animals such as cattle, pigs, and chickens. Moreover, increasing initiatives from regulatory authorities for prevention of diseases such as viral diseases in companion animals are expected to boost the global companion animal market growth over the forecast period. For instance, in 2016, The American Animal Hospital Association (AAHA) has commissioned a task force of veterinary oncology experts to develop a set of guidelines that will help veterinary teams work with pet owners for tailored treatment plans that will improve the quality of life of pets with cancer.

Market Dynamics

The increasing approval and launch of novel companion vaccines, adoption of inorganic growth strategies such as acquisitions and collaborations by key players operating in the market, and rising research and development of novel vaccines are expected to drive the growth of global companion animal vaccine market over the forecast period. For instance, in March 2019, Virbac, a French animal care company, launched a vaccine called CANILEISH to prevent canine leishmaniosis, due to the increasing prevalence of canine leishmaniosis in several regions across the globe, especially in Southern Europe and South America.

Moreover, in June 2018, Zoetis received approval from the U.S. Department of Agriculture for marketing its first monovalent vaccine Fostera Gold PCV, used in the pork industry for swine that includes two genotypes of porcine circovirus type 2 (PCV2).

Key features of the study

This report provides in-depth analysis of the global companion animal vaccine market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global companion animal vaccine market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Elanco Animal Health Incorporated, Boehringer Ingelheim GmbH, Ceva, Merck & Co., Inc., Virbac, Zoetis Inc, HIPRA, Biogenesis Bago, and Ourofino Animal Health.
Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansions and marketing tactics
The global companion animal vaccine market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global companion animal vaccine market.

Market Segmentation

Global Companion Animal Vaccine Market, By Product Type
- Attenuated Live Vaccine
- Conjugate Vaccine
- Inactivated Vaccine
- Subunit Vaccine
- Toxoid Vaccine
- DNA Vaccine
- Recombinant Vaccine
Global Companion Animal Vaccine Market, By Animal Type
- Canine
- Feline
- Equine
- Others
Global Companion Animal Vaccine Market, By Distribution Channel
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institute
- Others
Global Companion Animal Vaccine Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Company Profiles
- Elanco Animal Health Incorporated
- Boehringer Ingelheim GmbH
- Ceva Ltd.
- Merck & Co. Inc.
- Virbac
- Zoetis Inc.
- HIPRA
- Biogenesis Bago
- Ourofino Animal Health
- Croda International Plc
- KM Biologics
- Indian Immunological Ltd.
- Sinovac
- Kyoto Biken vLaboratories, Inc.
- HESTER BIOSCIENCES LIMITED
- Calier
- Bioveta

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Species Type
- Market Snippet, By Distribution Channel
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Product Launches/Approvals
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Companion Animal Vaccine Market, By Product Type, 2020- 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Attenuated Live Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Conjugate Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Inactivated Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Subunit Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Toxoid Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
DNA Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trend
Recombinant Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trend

5. Global Companion Animal Vaccine Market, By Species Type, 2020- 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Canine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Feline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Equine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Avians
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends

6. Global Companion Animal Vaccine Market, By Distribution Channel, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Veterinary Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Veterinary Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Veterinary Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)

7. Global Companion Animal Vaccine Market, By Region, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Elanco Animal Health Incorporated
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Boehringer Ingelheim GmbH
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Ceva Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Merck & Co. Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Virbac
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Zoetis Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- HIPRA
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Biogenesis Bago
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Ourofino Animal Health.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Croda International Plc
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- KM Biologics
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Indian Immunologicals Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Sinovac
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Kyoto Biken Laboratories, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- HESTER BIOSCIENCES LIMITED
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Calier
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Bioveta, a.s
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies